16-23470145-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015044.4(GGA2):c.1471G>T(p.Val491Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015044.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GGA2 | NM_015044.4 | c.1471G>T | p.Val491Leu | missense_variant | Exon 15 of 17 | ENST00000309859.8 | NP_055859.1 | |
GGA2 | XM_047433801.1 | c.1441G>T | p.Val481Leu | missense_variant | Exon 16 of 18 | XP_047289757.1 | ||
GGA2 | XM_047433802.1 | c.1360G>T | p.Val454Leu | missense_variant | Exon 15 of 17 | XP_047289758.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1471G>T (p.V491L) alteration is located in exon 15 (coding exon 15) of the GGA2 gene. This alteration results from a G to T substitution at nucleotide position 1471, causing the valine (V) at amino acid position 491 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.